SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-149412
Filing Date
2021-12-14
Accepted
2021-12-14 08:05:34
Documents
15
Period of Report
2021-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135322d2_8k.htm   iXBRL 8-K 46697
2 EXHIBIT 2.1 tm2135322d2_ex2-1.htm EX-2.1 637964
3 EXHIBIT 99.1 tm2135322d2_ex99-1.htm EX-99.1 27333
7 GRAPHIC tm2135322d2_ex99-1img01.jpg GRAPHIC 19542
  Complete submission text file 0001104659-21-149412.txt   1060617

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20211214.xsd EX-101.SCH 3052
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20211214_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20211214_pre.xml EX-101.PRE 22378
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2135322d2_8k_htm.xml XML 3613
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 211489730
SIC: 2834 Pharmaceutical Preparations